Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00434525 · ClinicalTrials.gov registry record · Phase 3

Laparoscopic Sleeve Gastrectomy With and Without Omentectomy

A Phase 3 study of Morbid Obesity, sponsored by North Texas Veterans Healthcare System.

Completed
Registry status
Phase 3
Development phase
30
Enrollment target
1
Study location

NCT00434525 is a Phase 3 study of Morbid Obesity that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 30 participants, below the 121-participant average among 24 other Morbid Obesity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00434525, a Phase 3 study of Morbid Obesity, has completed, sponsored by North Texas Veterans Healthcare System.

COMPLETED
Registry status
Phase 3
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

* The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.

Conditions Studied

Interventions

  • PROCEDURE Laparoscopic restrictive procedure
  • PROCEDURE Sleeve gastrectomy

Study Locations (1)

Texas

  • VA North Texas - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-01
Est. Completion 2009-12
Phase Phase 3

What the Registry Record Tells You About NCT00434525

The ClinicalTrials.gov registry entry for NCT00434525 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 121-participant average among 24 other Morbid Obesity trials with a reported enrollment target (75% lower). The listed sponsor is North Texas Veterans Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 2 interventions - of which Laparoscopic restrictive procedure is the first listed.

NCT00434525 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00434525 about?

NCT00434525 is a clinical study titled "Laparoscopic Sleeve Gastrectomy With and Without Omentectomy". * The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by slee...

What is the current status of trial NCT00434525?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2008-01. Estimated completion is 2009-12.

What conditions does trial NCT00434525 study?

This clinical trial studies the following conditions: Morbid Obesity.

What interventions are being tested in trial NCT00434525?

The interventions under investigation include: Laparoscopic restrictive procedure (PROCEDURE), Sleeve gastrectomy (PROCEDURE).

Who is sponsoring clinical trial NCT00434525?

This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00434525 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Morbid Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.